The Readout Loud

256: Explaining the E.U.'s pharma overhaul, Lilly's booming business, & a long-awaited drug approval

Apr 27, 2023
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
The Biggest Bio-Pharmonews of the Morning
02:01 • 2min
3
Eli Lilly's Mount Gero Sales for the Quarter Come in at $568.5 Million
04:07 • 2min
4
The FDA Approves a Biogen Treatment for ALS
06:08 • 2min
5
Voused: A Drug That Can Treat Recurrent Infections
08:35 • 2min
6
Al Nilum's Early Stage Treatment of Alzheimer's Disease
10:40 • 4min
7
The European Union's Plan to Democratize Access to New Medicines Across the Continent
15:02 • 2min
8
The EU's Disparity in Access to New Medicines
17:11 • 3min
9
The Politics of Investing in Europe
19:51 • 3min
10
What to Expect From Stats' New European Landfall
23:05 • 2min
11
Color Code: Stats on Racial Health Inequities
25:23 • 2min
12
The Readout Loud
27:11 • 2min